|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 20707669.6 (espacenet) (Federated) (European Patent Register), 20200306 | Patent/reg. no. and date | DK/EP 3935047, 20240807 | Publication date | 20220112 | Priority no. and date | WO PCT/EP2019/055793, 20190307 | EP pub. no. and date |
EP 3935047 20220112 | Effective date | | Applicant/owner | BioNTech SE, An der Goldgrube 12
55131 Mainz, DE | Applicant ref. no. | V2408-009-DK | Inventor | HENRY, Christophe, c/o BioNTech SE An der Goldgrube 12
55131 Mainz, DE | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | C07D 215/46 (2006.01) , C07D 471/04 (2006.01) | Title | FREMGANGSMÅDE TIL FREMSTILLING AF ET SUBSTITUERET IMIDAZOQUINOLIN | Int. application no. | EP2020056047 | Int. publication no. | WO2020178434 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |